Recently, we identified shikonin and its analogues were potent inhibitors to pyruvate kinase isozyme M2 (PKM2) or tumor M2-PK [30], which almost ubiquitously expresses in tumor cells [31] and plays important roles in cancer cell metabolism and growth [32], [33], [34]. The gene discussed is PKM; the disease is neoplasm.